Form 8-K - Current report:
SEC Accession No. 0001787306-25-000096
Filing Date
2025-06-17
Accepted
2025-06-17 16:52:21
Documents
13
Period of Report
2025-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20250612.htm   iXBRL 8-K 39372
2 EX-10.1 exhibit101.htm EX-10.1 33838
  Complete submission text file 0001787306-25-000096.txt   199182

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20250612.xsd EX-101.SCH 1770
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20250612_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20250612_pre.xml EX-101.PRE 13038
15 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20250612_htm.xml XML 2864
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 251054026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)